Hilbrands LB - Search Results

1

Tolerizing effects of co-stimulation blockade rest on functional dominance of CD4+CD25+ regulatory T cells.

Coenen JJ, Koenen HJ, van Rijssen E, Hilbrands LB, Joosten I. Coenen JJ, et al. Among authors: hilbrands lb. Transplantation. 2005 Jan 27;79(2):147-56. doi: 10.1097/01.tp.0000147460.93587.87. Transplantation. 2005. PMID: 15665762

2

The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab.

ter Meulen CG, Jacobs CW, Wetzels JF, Klasen IS, Hilbrands LB, Hoitsma AJ. ter Meulen CG, et al. Among authors: hilbrands lb. Transplantation. 2004 Jan 27;77(2):281-6. doi: 10.1097/01.TP.0000101702.73759.F3. Transplantation. 2004. PMID: 14742994

3

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells.

Coenen JJ, Koenen HJ, van Rijssen E, Hilbrands LB, Joosten I. Coenen JJ, et al. Among authors: hilbrands lb. Blood. 2006 Feb 1;107(3):1018-23. doi: 10.1182/blood-2005-07-3032. Epub 2005 Oct 6. Blood. 2006. PMID: 16210336 Free article.

4

CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade.

Coenen JJ, Koenen HJ, van Rijssen E, Boon L, Joosten I, Hilbrands LB. Coenen JJ, et al. Among authors: hilbrands lb. J Immunol. 2006 May 1;176(9):5240-6. doi: 10.4049/jimmunol.176.9.5240. J Immunol. 2006. PMID: 16621989

5

Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.

Emmer PM, van der Vlag J, Adema GJ, Hilbrands LB. Emmer PM, et al. Among authors: hilbrands lb. Transplantation. 2006 May 27;81(10):1451-9. doi: 10.1097/01.tp.0000208801.51222.bd. Transplantation. 2006. PMID: 16732184

6

Ex vivo expansion of human CD4+ CD25high regulatory T cells from transplant recipients permits functional analysis of small blood samples.

Kreijveld E, Koenen HJ, Hilbrands LB, Joosten I. Kreijveld E, et al. Among authors: hilbrands lb. J Immunol Methods. 2006 Jul 31;314(1-2):103-13. doi: 10.1016/j.jim.2006.06.001. Epub 2006 Jun 28. J Immunol Methods. 2006. PMID: 16860335

7

The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+ CD25- T cells.

Kreijveld E, Koenen HJ, Hilbrands LB, van Hooff HJ, Joosten I. Kreijveld E, et al. Among authors: hilbrands lb. Blood. 2007 Jan 1;109(1):244-52. doi: 10.1182/blood-2006-05-021931. Epub 2006 Aug 10. Blood. 2007. PMID: 16902146 Free article.

8

Allogeneic stimulation of naturally occurring CD4+CD25+ T cells induces strong regulatory capacity with increased donor-reactivity.

Coenen JJ, Koenen HJ, Emmer PM, van Rijssen E, Hilbrands LB, Joosten I. Coenen JJ, et al. Among authors: hilbrands lb. Transpl Immunol. 2007 Jun;17(4):237-42. doi: 10.1016/j.trim.2007.01.004. Epub 2007 Jan 31. Transpl Immunol. 2007. PMID: 17493525

9

KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation.

Kreijveld E, van der Meer A, Tijssen HJ, Hilbrands LB, Joosten I. Kreijveld E, et al. Among authors: hilbrands lb. Transplantation. 2007 Oct 27;84(8):1045-51. doi: 10.1097/01.tp.0000286097.11173.70. Transplantation. 2007. PMID: 17989611

10

The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.

Kreijveld E, Hilbrands LB, van Berkel Y, Joosten I, Allebes W. Kreijveld E, et al. Among authors: hilbrands lb. Transplantation. 2007 Nov 15;84(9):1092-6. doi: 10.1097/01.tp.0000285994.29305.b1. Transplantation. 2007. PMID: 17998862

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters